Cidara Therapeutics Other Current Liabilities

Cidara Therapeutics (CDTX) currently reports a other current liabilities of $90M as of September 2025. That compares with $40M in the prior-year period — up 126.0% year over year. Use the charts on this page to explore Cidara Therapeutics's other current liabilities history and peer comparisons.

Cidara Therapeutics's other current liabilities increased from $40M to $90M — a 126.0% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cidara Therapeutics reported $90M in other current liabilities as of September 2025. That compares with $40M in the prior-year period — up 126.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $90M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cidara Therapeutics, and consider following CDTX for alerts when major investors trade the stock.

Cidara Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $90M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDTX with unrelated industries.